The Potential Roles of Metallothionein as a Therapeutic Target for Cerebral Ischemia and Retinal Diseases

E-ISSN： 1873-4316|14|4|400-407

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.14, Iss.4, 2013-01, pp. : 400-407

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Hot Toptc: Metallothionein as a Therapeutic Molecular Target against Human Diseases)

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 4, 2013-03 ,pp. : 391-393

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Erythropoietin in Retinal and Optic Nerve Diseases

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 9, 2015-11 ,pp. : 1225-1234

Bentham Science Publishers

Access to resources Recommend Favorite

Roles and Therapeutic Potential of Metallothioneins in Neurodegenerative Diseases

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 4, 2013-03 ,pp. : 408-413

Bentham Science Publishers

Access to resources Recommend Favorite

TNF-Alpha as a Therapeutic Target in Inflammatory Diseases, Ischemia- Reperfusion Injury and Trauma

Current Medicinal Chemistry, Vol. 16, Iss. 24, 2009-08 ,pp. : 3152-3167

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Co-enzyme Q10 in Retinal Diseases

Current Medicinal Chemistry, Vol. 24, Iss. 39, 2017-12 ,pp. : 4329-4339

Bentham Science Publishers

Access to resources Recommend Favorite